Research and Development

The future of Roche and Biogen Idec’s rheumatoid arthritis drug ocrelizumab has been thrown into doubt after the manufacturers decided …

Pfizer and Bristol-Myers Squibb’s apixaban has shown promising results in a late-stage head-to-head trial with Sanofi-Aventis’ Lovenox. The oral anti-coagulant …

Pfizer has suffered a big setback with the oral Alzheimer’s disease treatment it is developing with biotech outfit Medivation. Investigational …

Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …

Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK …

Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …

Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …

Dr Rudolf Kwan has joined Buffalo, US-based  Kinex Pharmaceuticals as chief medical officer. He will be responsible for the design …

A round-up of recent developments in the clinical research arena includes proposals from the FDA on reporting falsified trials, Kendle’s …

Quotient Bioresearch partners its clients with a unique offering of leading-edge technologies and services for all stages of early drug …

Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …

The FDA and European Medicines Agency are to simplify the regulatory process for orphan medicines by agreeing to accept a …

Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …

 This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …

The government has attempted to ‘up the ante’ in dementia research by convening a ministerial group comprising charities, scientists, research …